EXAI — Exscientia Share News
0.000.00%
HealthcareSpeculativeMid Cap
- $1.24bn
- $900.27m
- £20.08m
Brief: Exscientia Achieves Milestones For Two Programmes In Sanofi Collaboration
Exscientia PLC reports results for the quarter ended in June - Earnings Summary
Deals of the day-Mergers and acquisitions
Biotech firm Recursion to buy smaller peer Exscientia for $688 million
Exscientia PLC expected to post a loss of 11 cents a share - Earnings Preview
Live Markets: Healthcare to swim along as AI rally broadens
Exscientia PLC expected to post a loss of 37 cents a share - Earnings Preview
Exscientia PLC reports results for the quarter ended in December - Earnings Summary
Exscientia PLC expected to post a loss of 34 cents a share - Earnings Preview
Exscientia PLC expected to post a loss of 34 cents a share - Earnings Preview
Exscientia fires CEO after probe over relationship with two employees
Brief: Exscientia Says Board Has Decided To Terminate Employment Of Andrew Hopkins As Co's CEO
Brief: Exscientia Receives Open Philanthropy Grant To Explore New Therapeutic Approach For Pandemic Influenza
Brief: Exscientia Details Pipeline Prioritisation Strategy
U.S. STOCKS ON THE MOVE-Gold miners, Goosehead Insurance, FedEx
U.S. STOCKS ON THE MOVE-Lululemon, Copper miners, Gold miners
U.S. STOCKS ON THE MOVE-Exscientia, Fresh Track Therapeutics, Pinterest
U.S. STOCKS ON THE MOVE-Exscientia, Fresh Track Therapeutics, Pinterest
Exscientia up on AI drug discovery pact with Merck KGaA